Cai Hong Bing, Ding Xiao Hua, Chen Chang Chun
Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center, Wuhan, PR China.
Oncology. 2009;76(3):157-61. doi: 10.1159/000195885. Epub 2009 Jan 28.
The objective of this study was to establish the prevalence and type distribution of human papillomavirus (HPV) in cervical cancer and cervical intraepithelial neoplasia (CIN) in Hubei, China.
A total of 112 patients with cervical cancer and 60 CIN II-III samples were obtained from women undergoing biopsy or surgery. HPV and typing were examined by the polymerase chain reaction (PCR) and sequencing.
HPV DNA was detected in 105 patients with cervical cancer (93.75%), HPV 16 being detected in 91 (81.25%) cases, and HPV 58 in 7 (6.25%) cases. HPV DNA was detected in 50 patients with CIN II-III (83.33%), HPV 16 being detected in 37 (61.67%) cases, HPV 58 in 5 cases (8.33%). HPV 18 was not common in this study. About 11% cervical cancer and 8.33% CIN II-III specimens exhibited multiple infections (p = 0.79).
The high prevalence of HPV 16 in Hubei, China, deserves attention as it has important implications for the usefulness of vaccine and the choice of diagnostic methods.
本研究旨在确定中国湖北地区宫颈癌及宫颈上皮内瘤变(CIN)中人类乳头瘤病毒(HPV)的流行情况及类型分布。
从接受活检或手术的女性中获取了112例宫颈癌患者及60例CIN II - III样本。采用聚合酶链反应(PCR)及测序技术检测HPV及其分型。
105例宫颈癌患者(93.75%)检测到HPV DNA,其中91例(81.25%)检测到HPV 16,7例(6.25%)检测到HPV 58。50例CIN II - III患者(83.33%)检测到HPV DNA,其中37例(61.67%)检测到HPV 16,5例(8.33%)检测到HPV 58。HPV 18在本研究中不常见。约11%的宫颈癌及8.33%的CIN II - III样本表现为多重感染(p = 0.79)。
中国湖北地区HPV 16的高流行率值得关注,因为这对疫苗的有效性及诊断方法的选择具有重要意义。